Publications
- Paricalcitol (19-nor-) and calcitriol (1,25-dihydroxycholecalciferol) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2011 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Immune system and the control of tumor growth2009 | Second Faculty of Medicine
- Plasmacytoid DCs, exposed to TSLP in synergy with TLR ligands, acquire significant potential towards Th2 polarization2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Selective Increase in Blood Dendritic Cell Antigen-3-Positive Dendritic Cells in Bronchoalveolar Lavage Fluid in Allergic Patients2012 | Second Faculty of Medicine
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials2011 | Second Faculty of Medicine
- Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease2011 | Second Faculty of Medicine
- Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation2010 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Third Faculty of Medicine
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells2009 | Second Faculty of Medicine
- Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis2007 | Second Faculty of Medicine
Loading network view...